| 1 | A1 | Human | F | 60 y | Breast (Bst) | Normal with hyperplasia | Diseased | +, 50% | - | - | - | | |
| 1 | A2 | Human | F | 44 y | Breast (Bst) | Normal with hyperplasia | Diseased | - | - | - | - | | |
| 1 | A3 | Human | F | 60 y | Breast (Bst) | Normal with hyperplasia | Diseased | ++, 80% | - | +++, 60% | +++, 70% | | |
| 1 | A4 | Human | F | 43 y | Breast (Bst) | Fibroadenosis | Diseased | ++, 80% | - | +, 20% | | T2N0M0 | |
| 1 | A5 | Human | F | 60 y | Breast (Bst) | Fibroadenoma | Tumor | ++, 80% | - | ++~+++, 40% | ++~+++, 60% | T3N0M0 | |
| 1 | A6 | Human | F | 48 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | +, 10% | - | - | +++, 50% | T2N0M0 | Grade III |
| 1 | A7 | Human | F | 65 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N0M0 | Grade III |
| 1 | A8 | Human | F | 69 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | - | | - | - | T3N1M0 | Grade II |
| 1 | A9 | Human | F | 53 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 5% | - | - | - | T2N0M0 | Grade II-III |
| 1 | A10 | Human | F | 69 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | +++ | +, 10% | - | T2N0M0 | Grade II |
| 1 | A11 | Human | F | 55 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | - | - | T2N0M0 | Grade II |
| 1 | A12 | Human | F | 68 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | +, 10% | - | - | - | T3N1M0 | Grade I |
| 1 | A13 | Human | F | 56 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | | | | | T2N0M0 | Grade II |
| 1 | A14 | Human | F | 35 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | - | - | - | +++, 80% | T3N1M0 | Grade II |
| 1 | A15 | Human | F | 48 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N0M0 | Grade III |
| 1 | B1 | Human | F | 60 y | Breast (Bst) | Normal with hyperplasia | Diseased | +, 50% | - | - | - | | |
| 1 | B2 | Human | F | 44 y | Breast (Bst) | Normal with hyperplasia | Diseased | - | - | - | - | | |
| 1 | B3 | Human | F | 60 y | Breast (Bst) | Normal with hyperplasia | Diseased | ++, 80% | - | +++, 60% | +++, 70% | | |
| 1 | B4 | Human | F | 43 y | Breast (Bst) | Fibroadenosis | Diseased | ++, 80% | - | +, 20% | | T2N0M0 | |
| 1 | B5 | Human | F | 60 y | Breast (Bst) | Fibroadenoma | Tumor | ++, 80% | - | ++~+++, 40% | ++~+++, 60% | T3N0M0 | |
| 1 | B6 | Human | F | 48 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | +, 10% | - | - | +++, 50% | T2N0M0 | Grade III |
| 1 | B7 | Human | F | 65 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N0M0 | Grade III |
| 1 | B8 | Human | F | 69 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | - | | - | - | T3N1M0 | Grade II |
| 1 | B9 | Human | F | 53 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 5% | - | - | - | T2N0M0 | Grade II-III |
| 1 | B10 | Human | F | 69 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | +++ | +, 10% | - | T2N0M0 | Grade II |
| 1 | B11 | Human | F | 55 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | - | - | T2N0M0 | Grade II |
| 1 | B12 | Human | F | 68 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | +, 10% | - | - | - | T3N1M0 | Grade I |
| 1 | B13 | Human | F | 56 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | | | | | T2N0M0 | Grade II |
| 1 | B14 | Human | F | 35 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | - | - | - | +++, 80% | T3N1M0 | Grade II |
| 1 | B15 | Human | F | 48 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N0M0 | Grade III |
| 1 | C1 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | - | - | T2N0M0 | Grade II |
| 1 | C2 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | - | - | T2N0M0 | Grade II |
| 1 | C3 | Human | F | 60 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | +++ | - | - | T2N0M0 | Grade II |
| 1 | C4 | Human | F | 41 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +, 20% | T2N0M0 | Grade I-II |
| 1 | C5 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | ++~+++ | - | - | T2N0M0 | Grade II |
| 1 | C6 | Human | F | 49 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | +, 5% | - | T1N0M0 | Grade I-II |
| 1 | C7 | Human | F | 70 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 10% | - | +++, 60% | - | T2N1M0 | Grade I |
| 1 | C8 | Human | F | 55 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 5% | - | +, 10% | - | T2N0M0 | Grade III |
| 1 | C9 | Human | F | 52 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | + | - | - | T2N0M0 | Grade I-II |
| 1 | C10 | Human | F | 74 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | +~++ | +, 5% | +++, 90% | T1N0M0 | Grade III |
| 1 | C11 | Human | F | 45 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | - | +++, 40% | T3N0M0 | Grade II |
| 1 | C12 | Human | F | 57 y | Breast (Bst) | Sarcoma | Malignant | +, 50% | - | - | - | T3N0M0 | |
| 1 | C13 | Human | F | 45 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | - | - | - | +++, 90% | T2N0M0 | |
| 1 | C14 | Human | F | 42 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade II |
| 1 | C15 | Human | F | 42 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | ++ | - | - | | Grade II |
| 1 | D1 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | - | - | T2N0M0 | Grade II |
| 1 | D2 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | - | - | T2N0M0 | Grade II |
| 1 | D3 | Human | F | 60 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | +++ | - | - | T2N0M0 | Grade II |
| 1 | D4 | Human | F | 41 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +, 20% | T2N0M0 | Grade I-II |
| 1 | D5 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | ++~+++ | - | - | T2N0M0 | Grade II |
| 1 | D6 | Human | F | 49 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | +, 5% | - | T1N0M0 | Grade I-II |
| 1 | D7 | Human | F | 70 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 10% | - | +++, 60% | - | T2N1M0 | Grade I |
| 1 | D8 | Human | F | 55 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 5% | - | +, 10% | - | T2N0M0 | Grade III |
| 1 | D9 | Human | F | 52 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | + | - | - | T2N0M0 | Grade I-II |
| 1 | D10 | Human | F | 74 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | +~++ | +, 5% | +++, 90% | T1N0M0 | Grade III |
| 1 | D11 | Human | F | 45 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | - | +++, 40% | T3N0M0 | Grade II |
| 1 | D12 | Human | F | 57 y | Breast (Bst) | Sarcoma | Malignant | +, 50% | - | - | - | T3N0M0 | |
| 1 | D13 | Human | F | 45 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | - | - | - | +++, 90% | T2N0M0 | |
| 1 | D14 | Human | F | 42 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade II |
| 1 | D15 | Human | F | 42 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | ++ | - | - | | Grade II |
| 1 | E1 | Human | F | 92 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | ++~+++, 80% | ++~+++, 50% | T1N0M0 | Grade II |
| 1 | E2 | Human | F | 27 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | - | - | T3N0M0 | Grade III |
| 1 | E3 | Human | F | 40 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | + | - | - | T1N0M0 | Grade II |
| 1 | E4 | Human | F | 43 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N0M0 | Grade II |
| 1 | E5 | Human | F | 44 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | +~++ | - | - | T3N1M0 | Grade III |
| 1 | E6 | Human | F | 82 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T3N1M0 | Grade I |
| 1 | E7 | Human | F | 58 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | | +~++, 40% | T3N0M0 | Grade II |
| 1 | E8 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N0M0 | Grade II-III |
| 1 | E9 | Human | F | 40 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 15% | - | ++, 40% | +++, 90% | T1N0M0 | Grade II |
| 1 | E10 | Human | F | 46 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | + | - | - | T2N0M0 | Grade II |
| 1 | E11 | Human | F | 82 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 20% | | - | +++, 70% | T2N0M0 | Grade II |
| 1 | E12 | Human | F | 38 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | ++, 60% | ++~+++ | - | +++, 60% | T2N0M0 | Grade II |
| 1 | E13 | Human | F | 74 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | ++~+++, 60% | - | - | ++~+++, 30% | T1N0M0 | Grade I |
| 1 | E14 | Human | F | 75 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | ++, 10% | | Grade III |
| 1 | E15 | Human | F | 61 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | | Grade I |
| 1 | F1 | Human | F | 92 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | ++~+++, 80% | ++~+++, 50% | T1N0M0 | Grade II |
| 1 | F2 | Human | F | 27 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | | - | - | T3N0M0 | Grade III |
| 1 | F3 | Human | F | 40 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | + | - | - | T1N0M0 | Grade II |
| 1 | F4 | Human | F | 43 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N0M0 | Grade II |
| 1 | F5 | Human | F | 44 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | +~++ | - | - | T3N1M0 | Grade III |
| 1 | F6 | Human | F | 82 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T3N1M0 | Grade I |
| 1 | F7 | Human | F | 58 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | | +~++, 40% | T3N0M0 | Grade II |
| 1 | F8 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N0M0 | Grade II-III |
| 1 | F9 | Human | F | 40 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 15% | - | ++, 40% | +++, 90% | T1N0M0 | Grade II |
| 1 | F10 | Human | F | 46 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | + | - | - | T2N0M0 | Grade II |
| 1 | F11 | Human | F | 82 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 20% | | - | +++, 70% | T2N0M0 | Grade II |
| 1 | F12 | Human | F | 38 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | ++, 60% | ++~+++ | - | +++, 60% | T2N0M0 | Grade II |
| 1 | F13 | Human | F | 74 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | ++~+++, 60% | - | - | ++~+++, 30% | T1N0M0 | Grade I |
| 1 | F14 | Human | F | 75 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | ++, 10% | | Grade III |
| 1 | F15 | Human | F | 61 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | | Grade I |
| 1 | G1 | Human | F | 42 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +, 60% | T2N0M0 | Grade III |
| 1 | G2 | Human | F | 81 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +~++, 30% | - | - | +~++, 15% | T3N1M0 | Grade I-II |
| 1 | G3 | Human | F | 60 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | ++~+++ | - | - | T2N1M0 | Grade II |
| 1 | G4 | Human | F | 53 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +~++, 50% | T2N1M0 | Grade III |
| 1 | G5 | Human | F | 32 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 5% | + | - | ++, 20% | T3N1M0 | Grade III |
| 1 | G6 | Human | F | 62 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | +~++, 30% | - | +, 10% | +++, 90% | T1N0M0 | Grade I-II |
| 1 | G7 | Human | F | 41 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | +, 5% | +++, 80% | T3N0M0 | Grade II |
| 1 | G8 | Human | F | 41 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +, 5% | T2N0M0 | Grade II-III |
| 1 | G9 | Human | F | 65 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade III |
| 1 | G10 | Human | F | 43 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +++, 10% | T3N1M0 | Grade II-III |
| 1 | G11 | Human | F | 59 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N0M0 | Grade II-III |
| 1 | G12 | Human | F | 35 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | ++, 50% | T2N0M0 | Grade II |
| 1 | G13 | Human | F | 35 y | Breast (Bst) | Inflammation, Plasmacytic | Inflammatory | - | - | - | - | T2N0M0 | |
| 1 | G14 | Human | F | 65 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade II-III |
| 1 | G15 | Human | F | 37 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade II |
| 1 | H1 | Human | F | 42 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +, 60% | T2N0M0 | Grade III |
| 1 | H2 | Human | F | 81 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +~++, 30% | - | - | +~++, 15% | T3N1M0 | Grade I-II |
| 1 | H3 | Human | F | 60 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | ++~+++ | - | - | T2N1M0 | Grade II |
| 1 | H4 | Human | F | 53 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +~++, 50% | T2N1M0 | Grade III |
| 1 | H5 | Human | F | 32 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 5% | + | - | ++, 20% | T3N1M0 | Grade III |
| 1 | H6 | Human | F | 62 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +~++, 30% | - | +, 10% | +++, 90% | T1N0M0 | Grade I-II |
| 1 | H7 | Human | F | 41 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | +, 5% | +++, 80% | T3N0M0 | Grade II |
| 1 | H8 | Human | F | 41 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +, 5% | T2N0M0 | Grade II-III |
| 1 | H9 | Human | F | 65 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade III |
| 1 | H10 | Human | F | 43 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +++, 10% | T3N1M0 | Grade II-III |
| 1 | H11 | Human | F | 59 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N0M0 | Grade II-III |
| 1 | H12 | Human | F | 35 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | ++, 50% | T2N0M0 | Grade II |
| 1 | H13 | Human | F | 35 y | Breast (Bst) | Inflammation, Plasmacytic | Inflammatory | - | - | - | - | T2N0M0 | |
| 1 | H14 | Human | F | 65 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade II-III |
| 1 | H15 | Human | F | 37 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade II |
| 1 | I1 | Human | F | 46 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T3N0M0 | Grade III |
| 1 | I2 | Human | F | 40 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 5% | - | +, 2% | +++, 90% | T2N0M0 | Grade II |
| 1 | I3 | Human | F | 48 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | ++ | - | - | T2N0M0 | Grade II-III |
| 1 | I4 | Human | F | 61 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | +, 2% | | T2N1M0 | Grade III |
| 1 | I5 | Human | F | 43 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | | T2N0M0 | Grade III |
| 1 | I6 | Human | F | 62 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | | T1N0M0 | Grade III |
| 1 | I7 | Human | F | 53 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade III |
| 1 | I8 | Human | F | 64 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | +, 10% | - | T2N1M0 | Grade II |
| 1 | I9 | Human | F | 41 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade I |
| 1 | I10 | Human | F | 65 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | +, 30% | +~++, 5~10% | T1N0M0 | Grade II-III |
| 1 | I11 | Human | F | 37 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +++, 70% | T2N0M0 | Grade I-II |
| 1 | I12 | Human | F | 45 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade II-III |
| 1 | I13 | Human | F | 53 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | +~++, 2% | - | +++, 70% | - | T3N1M0 | Grade II |
| 1 | I14 | Human | F | 58 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade II-III |
| 1 | I15 | Human | F | 80 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 10% | - | - | +++, 90% | T3N0M0 | Grade II |
| 1 | J1 | Human | F | 46 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T3N0M0 | Grade III |
| 1 | J2 | Human | F | 40 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 5% | - | +, 2% | +++, 90% | T2N0M0 | Grade II |
| 1 | J3 | Human | F | 48 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | ++ | - | - | T2N0M0 | Grade II-III |
| 1 | J4 | Human | F | 61 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | +, 2% | | T2N1M0 | Grade III |
| 1 | J5 | Human | F | 43 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | | T2N0M0 | Grade III |
| 1 | J6 | Human | F | 62 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | | T1N0M0 | Grade III |
| 1 | J7 | Human | F | 53 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade III |
| 1 | J8 | Human | F | 64 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | +, 10% | - | T2N1M0 | Grade II |
| 1 | J9 | Human | F | 41 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade I |
| 1 | J10 | Human | F | 65 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | +, 30% | +~++, 5~10% | T1N0M0 | Grade II-III |
| 1 | J11 | Human | F | 37 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | +++, 70% | T2N0M0 | Grade I-II |
| 1 | J12 | Human | F | 45 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade II-III |
| 1 | J13 | Human | F | 53 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +~++, 2% | - | +++, 70% | - | T3N1M0 | Grade II |
| 1 | J14 | Human | F | 58 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | - | - | - | - | T2N1M0 | Grade II-III |
| 1 | J15 | Human | F | 80 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | +, 10% | - | - | +++, 90% | T3N0M0 | Grade II |